[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338268-105":59,"doc-detail-338268-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-and-prognostic-impact-of-galectin-7-in-human-lung-cancer-research-article","Expression and prongostic impact of galectin-7 in human lung cancer - Research Article","","Malignant lung tumors remain the leading cause of cancer-related death worldwide, and prognostic biomarkers are being sought to improve detection and patient stratification. This study examines galectin-7 expression and its relationship to clinicopathological features and overall survival across lung cancer types. Immunohistochemistry was performed in 308 cases (adenocarcinoma, squamous cell carcinoma, and SCLC), showing most evident expression in squamous tumors and no galectin-7 expression in SCLC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-and-prognostic-impact-of-galectin-7-in-human-lung-cancer-research-article/338268/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-and-prognostic-impact-of-galectin-7-in-human-lung-cancer-research-article/338268.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of the study about galectin-7 in lung cancer?","Question",{"text":112,"@type":113},"To investigate galectin-7 expression in relation to clinicopathological features and overall survival in patients with different lung cancer types.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was galectin-7 expression measured, and in how many cases?",{"text":117,"@type":113},"Galectin-7 expression was analyzed by immunohistochemistry in 308 lung cancer cases.",{"name":119,"@type":110,"acceptedAnswer":120},"Which lung cancer type showed the most evident galectin-7 expression in this study?",{"text":121,"@type":113},"Squamous cell lung carcinoma showed the most evident galectin-7 expression, while negative expression was found in all SCLC patients.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338268,1790719496,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","®  \n Observational Study   \nExpression and prongostic impact of galectin-7 inhuman lung cancer  \nAnna Tirilomi, MDa , Petros Tirilomis, MDb , Omar Elakad, MDc , Sha Yao, MDc , Marc Hinterthaner, MDa , Bernhard C. Danner, MDa , Philipp Ströbel, MDc , Theodor Tirilomis, MDa , Hanibal Bohnenberger, MDc , Alexander von Hammerstein-Equord, MDa ,*  \n\n| Abstract\u003Cbr>Malignant tumors of the lung are the leading cancers worldwide. Prognostic biomarkers continue to be investigated for the detection and stratification of lung cancer for clinical use. In breast cancer cells and in lymphomas, the overexpression of galectin-7 led to increased metastasis. In lung cancer, squamous cell carcinoma, galectin-7 was also identified as a factor promoting metastasis. In this study, we investigated the expression of galectin-7 in relation to clinicopathological features and overall survival in patients with different types of lung cancer. By immunohistochemistry, expression of galectin-7 was analyzed in 308 cases of lung cancer;\u003Cbr>108 cases of adenocarcinoma, 193 cases of squamous cell lung carcinoma and 7 cases of small cell lung cancer (SCLC) and correlated with clinicopathological characteristics as well as patients’ overall survival. Immunohistochemical detection of galectin-7 expression was most evident in squamous cell lung carcinoma (36 .27%), followed by adenocarcinoma (5 .55%) . Negative expression of galectin-7 was found in all patients with SCLC. No significant correlation was found in patients with squamous cell lung carcinoma. Within the adenocarcinoma and squamous cell lung carcinoma subgroups, there were statistically significant correlations between the expression of galectin-7 and some clinicopathologic features of the patients. In our study, we were able to show that galectin-7 could serve as a new prognostic biomarker and is also a potential new drug target in non-small cell lung cancer. |\n| --- |\n| Abbreviations: AC = adenocarcinoma, NSCLC = non-small cell lung cancer, SCLC = small cell lung cancer, SQCLC = squamous cell lung carcinoma. |\n| Keywords: galectin-7 , human lung cancer |\n\n1. Introduction  \nLung cancer is worldwide the leading cause of cancer-associated mortality.[1] Lung cancer is divided into small cell lung cancer (SCLC) and non-SCLC (NSCLC) . The latter is further subdivided into adenocarcinoma (AC) and squamous cell lung carcinoma (SQCLC) .[2] The treatment of lung cancer depends on the TNM classification and Union for international cancer control, UICC stage.[3] Surgery is the treatment of choice for patients with stage I or II lung cancer if there are no contraindications. The treatment claim is curative.[4–6] Patients with stage III NSCLC are rarely treated surgically. Most patients receive radiotherapy and/ or chemotherapy.[7] In addition, lung cancer can be divided into many molecularly heterogeneous subgroups that are constantly evolving and potentially actionable. New strategies for molecular diagnostics and targeted therapies for lung cancer are being researched in order to detect and treat them.[8–10]  \nThe protein galectin-7 is in humans encoded by the LGALS7 gene.[11,12] Galectin-7 was originally considered a marker for the differentiation status of keratinocytes.[11,12] Apoptotic keratinocytes expressed a high amount of galectin-7 .[13] In colon cancer cells, galectin-7 has been shown to act as an apoptosis regulator.[14] Furthermore, it was shown that galectin-7 makes tumor cells more susceptible to apoptotic stimuli.[15,16] On the other hand, the growth of neuroblastoma cells was reduced by extracellular binding of galectin-7 to cell surface receptors. There was no evidence of classical apoptosis.[17]  \nIn breast cancer cells, overexpression of galectin-7 led to a significant increase in lung metastases and osteolytic lesions. Galectin-7 is therefore being further investigated as a potential target for the specific detection and therapeutic inhibition of metastatic breast cancer.[18] In patients with ","cbCaiqLPM12DKCFk","https://ap.wps.com/l/cbCaiqLPM12DKCFk","pdf",693441,"English","# Abstract\n# Introduction\n## Galectin-7 biology and prior evidence\n# Methods (as described in abstract)\n# Results (as described in abstract)\n# Conclusion","[{\"question\":\"What was the main aim of the study about galectin-7 in lung cancer?\",\"answer\":\"To investigate galectin-7 expression in relation to clinicopathological features and overall survival in patients with different lung cancer types.\"},{\"question\":\"How was galectin-7 expression measured, and in how many cases?\",\"answer\":\"Galectin-7 expression was analyzed by immunohistochemistry in 308 lung cancer cases.\"},{\"question\":\"Which lung cancer type showed the most evident galectin-7 expression in this study?\",\"answer\":\"Squamous cell lung carcinoma showed the most evident galectin-7 expression, while negative expression was found in all SCLC patients.\"}]","Expression and prongostic impact of galectin-7 in human lung cancer - Research Article | PDF",1790022842,13,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a554a3fc35a23691f826722115ba853.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20f6b206b083fce529ea26096c795a26.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c611958cdc5511c9b98acde6796a2bce.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0dda811db82c16731bfca7d33b8630fc.webp",980,1306]